Trump Announces Deal to Drop Obesity Drug Prices to as Little as $150 a Month

Source: New York Times Business | Published: November 6, 2025, 6:32 pm | Read Original

Neutral 0.0

Trump Announces Deal to Drop Obesity Drug Prices to as Little as $150 a Month

President Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices on hugely popular weight-loss drugs for Medicare, Medicaid and American patients who pay with their own money.

Read Source Login to use Pulse AI

Pulse AI Analysis

Pulse analysis not available yet. Click "Get Pulse" above.

This analysis was generated using Pulse AI, Glideslope's proprietary AI engine designed to interpret market sentiment and economic signals. Results are for informational purposes only and do not constitute financial advice.

More Like This

Market & Industry Analysis Straight to Your Inbox

Glideslope AI

Trump Announces Deal to Drop Obesity Drug Prices to as Little as $150 a Month

President Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices on hugely popular weight-loss drugs for Medicare, Medicaid and American patients who pay with their own money.

New York Times Business • Nov 6, 2025 • Found on Glideslope.ai

Post hash: vgxgely • glideslope.ai/post/vgxgely

Sentiment

Neutral • Score: 0.0

-100 (Bearish) +100 (Bullish)

Fraywire Market Portal, Breaking Metrics Newsletter, and Glideslope AI are designed for informational purposes only. The content provided across these platforms—including, but not limited to, stock and crypto watchlists, price tracking, trade tracking, sentiment analysis, and news articles—should not be construed as financial advice or research reports. Users are encouraged to conduct their own research and consult with qualified financial professionals before making any investment decisions. While we strive to ensure the accuracy, completeness, and reliability of the information provided, Fraywire, Breaking Metrics, and Glideslope AI make no guarantees or warranties regarding the content's validity. By using these platforms, you acknowledge and agree that you are solely responsible for your own investment decisions and actions. Fraywire, Breaking Metrics, and Glideslope AI shall not be held liable for any losses or damages resulting from the use of the information provided.

Get Connected

Fraywire & Glideslope AI are Breaking Metrics productions.
Contact the developer for advertising opportunities, questions, and more at roy@rmahd.com

○ Subscribe
○ Fraywire+
○ Glideslope AI
○ Blog
○ RMAHD
○ Merch!

Pulse AI Analysis

Related Insights

More Like This

Robinhood shares drop 8% despite reporting Q3 crypto revenue surge: CNBC Crypto World

Trump unveils deals to lower US weight-loss drug prices

Trump Announces $250 Weight Loss Drugs In Latest ‘TrumpRx’ Deal

Boeing criminal case linked to deadly 737 crashes dropped

Trump White House confirms pricing deal with weight-loss-drug giants Eli Lilly, Novo Nordisk

Dow drops 400 points as AI stocks resume their decline, Nasdaq falls 1.9%: Live updates

Market & Industry Analysis Straight to Your Inbox

My Notes